Literature DB >> 30703774

Hypogonadism in Children with a Previous History of Cancer: Endocrine Management and Follow-Up.

Hanneke M van Santen1,2, Marry M van den Heuvel-Eibrink3, Marianne D van de Wetering3, W Hamish Wallace4.   

Abstract

Hypogonadism after treatment for childhood cancer is a recognized complication and its cause may be subdivided into primary gonadal failure and central hypogonadism. Here, we provide an overview of the risk factors for the development of hypogonadism, assessment and potential interventions and give a summary of the current recommendations for management and follow-up of hypogonadism in childhood cancer survivors. The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Chemotherapy; Hypogonadism; Late effects; Premature ovarian failure

Mesh：

Year:  2019        PMID： 30703774      PMCID： PMC6615280          DOI： 10.1159/000495943

Source DB:  PubMed          Journal:  Horm Res Paediatr        ISSN： 1663-2818            Impact factor:   2.852


  62 in total

Review 1.  Impact of cancer treatment on uterine function.

Authors:  Hilary O D Critchley; W Hamish B Wallace
Journal:  J Natl Cancer Inst Monogr       Date:  2005

2.  Cardiovascular effects of physiological and standard sex steroid replacement regimens in premature ovarian failure.

Authors:  Jeremy P Langrish; Nicholas L Mills; Louise E Bath; Pamela Warner; David J Webb; Christopher J Kelnar; Hilary O D Critchley; David E Newby; W Hamish B Wallace
Journal:  Hypertension       Date:  2009-03-30       Impact factor: 10.190

3.  Low inhibin B levels alone are not a reliable marker of dysfunctional spermatogenesis in childhood cancer survivors.

Authors:  R Rendtorff; M Beyer; A Müller; R Dittrich; C Hohmann; T Keil; G Henze; A Borgmann
Journal:  Andrologia       Date:  2011-07-05       Impact factor: 2.775

4.  Physiological versus standard sex steroid replacement in young women with premature ovarian failure: effects on bone mass acquisition and turnover.

Authors:  Patricia M Crofton; Nancy Evans; Louise E Bath; Pamela Warner; Tessa J Whitehead; Hilary O D Critchley; Christopher J H Kelnar; W Hamish B Wallace
Journal:  Clin Endocrinol (Oxf)       Date:  2010-12       Impact factor: 3.478

5.  Predicting age of ovarian failure after radiation to a field that includes the ovaries.

Authors:  W Hamish B Wallace; Angela B Thomson; Frank Saran; Tom W Kelsey
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-07-01       Impact factor: 7.038

Review 6.  Primary ovarian insufficiency.

Authors:  Michel De Vos; Paul Devroey; Bart C J M Fauser
Journal:  Lancet       Date:  2010-08-11       Impact factor: 79.321

7.  Is inhibin B a potential marker of gonadotoxicity in prepubertal children treated for cancer?

Authors:  P M Crofton; A B Thomson; A E M Evans; N P Groome; L E Bath; C J H Kelnar; W H B Wallace
Journal:  Clin Endocrinol (Oxf)       Date:  2003-03       Impact factor: 3.478

8.  Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin's lymphoma with chemotherapy during childhood.

Authors:  Robert D van Beek; Marij Smit; Marry M van den Heuvel-Eibrink; Frank H de Jong; Friederike G Hakvoort-Cammel; Cor van den Bos; Henk van den Berg; Rob F A Weber; Rob Pieters; Sabine M P F de Muinck Keizer-Schrama
Journal:  Hum Reprod       Date:  2007-11-02       Impact factor: 6.918

9.  Fertility of male survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.

Authors:  Daniel M Green; Toana Kawashima; Marilyn Stovall; Wendy Leisenring; Charles A Sklar; Ann C Mertens; Sarah S Donaldson; Julianne Byrne; Leslie L Robison
Journal:  J Clin Oncol       Date:  2009-11-30       Impact factor: 44.544

10.  Fertility of female survivors of childhood cancer: a report from the childhood cancer survivor study.

Authors:  Daniel M Green; Toana Kawashima; Marilyn Stovall; Wendy Leisenring; Charles A Sklar; Ann C Mertens; Sarah S Donaldson; Julianne Byrne; Leslie L Robison
Journal:  J Clin Oncol       Date:  2009-04-13       Impact factor: 44.544
View more
  2 in total

1.  Long-term Follow-up Care for Childhood, Adolescent, and Young Adult Cancer Survivors.

Authors:  Melissa M Hudson; Smita Bhatia; Jacqueline Casillas; Wendy Landier
Journal:  Pediatrics       Date:  2021-09       Impact factor: 9.703

Review 2.  Bone mineral density surveillance for childhood, adolescent, and young adult cancer survivors: evidence-based recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group.

Authors:  Jenneke E van Atteveld; Renée L Mulder; Marry M van den Heuvel-Eibrink; Melissa M Hudson; Leontien C M Kremer; Roderick Skinner; W Hamish Wallace; Louis S Constine; Claire E Higham; Sue C Kaste; Riitta Niinimäki; Sogol Mostoufi-Moab; Nathalie Alos; Danilo Fintini; Kimberly J Templeton; Leanne M Ward; Eva Frey; Roberto Franceschi; Vesna Pavasovic; Seth E Karol; Nadia L Amin; Lynda M Vrooman; Arja Harila-Saari; Charlotte Demoor-Goldschmidt; Robert D Murray; Edit Bardi; Maarten H Lequin; Maria Felicia Faienza; Olga Zaikova; Claire Berger; Stefano Mora; Kirsten K Ness; Sebastian J C M M Neggers; Saskia M F Pluijm; Jill H Simmons; Natascia Di Iorgi
Journal:  Lancet Diabetes Endocrinol       Date:  2021-07-30       Impact factor: 44.867
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.